Ainos

AIMD

Market cap $16.4M

Overview Fund Activity

3.45 USD

+0.05

1.47%

At close Updated Sep 16, 4:00 PM EDT

1 day

1.47%

5 days

2.07%

1 month

2.99%

3 months

36.9%

6 months

32.18%

Year to date

38%

1 year

37.45%

5 years

-96.23%

10 years

-96.23%

About: Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Employees: 44

Healthcare Medical Devices

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.12% less ownership

Funds ownership: 0.15% [Q1] → 0.03% (-0.12%) [Q2]

33% less funds holding

Funds holding: 12 [Q1] → 8 (-4) [Q2]

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

71% less capital invested

Capital invested by funds: $55.3K [Q1] → $16.2K (-$39.1K) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

See Fund Rankings

Financial journalist opinion

Based on 4 articles about AIMD published over the past 30 days

Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose

Partnership to accelerate commercialization of Ainos' AI Nose across semiconductors, healthcare, and smart manufacturing Topco brings 35 years of trusted global supply chain ties and customer access SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 16, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a pioneer in AI-powered scent digitization, today announced it has signed a distribution agreement with Topco Scientific Co., Ltd. (TWSE: 5434, "Topco"), one of Taiwan's leading semiconductor solution providers.

Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose

Ainos to Showcase AI Nose at SEMICON Taiwan 2025

AI Nose and Smell Language Model debut at SEMICON Taiwan 2025, bringing scent intelligence to the global semiconductor stage. Trainable, portable, cloud-connected AI Nose with SaaS model turns scent into insights for smart manufacturing SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it will showcase its AI Nose industrial module at SEMICON Taiwan 2025, held September 10-12 at the Taipei Nangang Exhibition Center.

Ainos to Showcase AI Nose at SEMICON Taiwan 2025

Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up

From biotech to SmellTech, Ainos transforms as a first mover in next-gen sensory AI Proprietary smell language model and scent data create unique competitive moat SmellTech flywheel spins toward 2026 scale-up, turning data into recurring revenue SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting AI Nose's first-mover breakthrough in giving AI the sense of smell, along with the Company's commercialization roadmap and pathway to profitability. The report draws insights from a management fireside chat on August 20, 2025.

Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up

Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation

Early revenues and $2.1M SmellTech-as-a-Service order set the stage for large-scale commercialization in 2026 Robotics and industrial deployments expand long-term growth runway beyond healthcare SAN DIEGO, CA / ACCESS Newswire / August 19, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has assumed coverage of Ainos under its Technology research platform, transitioning from its prior coverage under the Emerging Growth category. This move underscores Ainos' strategic transformation from biotech roots to a multi-sector AI technology innovator, with its proprietary AI Nose platform poised to ignite the Company's next phase of growth across healthcare, robotics, and industrial applications.

Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation

Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare

Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments Underway SmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead in Scent Intelligence. Debuting at Automation Taipei 2025 in Partnership with Kenmec and ugo SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today launched its first commercial AI Nose module optimized for industrial and healthcare settings, marking a pivotal milestone in the global commercialization of AI-powered digital olfaction.

Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare

Ainos Reports Second Quarter 2025 Financial Results

1H 2025 Kicks Off AI Nose's Growing Commercial Momentum with First Senior Care Revenue and New Strategic Partnerships AI Nose 90-Day Roadmap to Power 2H 2025, with First Multi-Year $2.1M Order and Traction Across Robotics, Semiconductors, and Smart Manufacturing SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-driven scent digitization, today announced its financial results for the second quarter ended June 30, 2025. Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "We're thrilled that our proprietary AI-powered scent digitization platform, AI Nose, has entered the commercial execution phase.

Ainos Reports Second Quarter 2025 Financial Results

Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET. Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment.

Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025

Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting

First Revenue-Generating Milestone for AI Nose Smell Language Model in High-Value Industrial Applications Ainos Building Commercial Momentum with Multi-Site Deployments Underway in Japan and Taiwan SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 6, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured a three-year subscription-based order valued at $2.1 million with ASE Technology Holding Co., Ltd. ("ASEH"), the world's largest provider of semiconductor assembly and test services.

Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting

Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome

Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune Disease SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 4, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech company pioneering smelltech and immune therapeutics, today announced that its investigational low-dose oral interferon-alpha drug candidate, VELDONA®, has received formal approval from Taiwan's Food and Drug Administration (TFDA) to initiate a clinical study for primary Sjögren's syndrome (pSS). The open-label study, titled "An open-label study to evaluate the efficacy of VELDONA® in patients with primary Sjögren's Syndrome" (Study No.

Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome

Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation

AI Nose delivers accuracy and versatility, driving scalable growth across healthcare, industrial and robotics markets Technology, data moat, and strategic partnerships position Ainos for accelerated commercial readiness and expansion SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research has published a recap of its recent Small-Cap Spotlight podcast. The report highlights the Company's AI Nose platform, an advanced smell digitization technology powered by artificial intelligence and built on over a decade of innovation, a deep data moat, strategic partnerships, and a clear commercialization roadmap.

Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation

See News Rankings

Charts implemented using Lightweight Charts™